BRCA1 and breast cancer: As aberrant BRCA1 promoter methylation is found in approximately 10% of sporadic breast cancers (Shakeri et al, 2016), we first measured the levels of epigenetic silencing of BRCA1 and analyzed BRCA1 expression and nuclear foci formation in PDX samples.